Cellmid (ASX:CDY) acquires BLC Cosmetics, appoints board leadership
Cellmid (CDY) acquires BLC Cosmetics from HLG Limited (HNG)The company has today…
Cellmid Limited (ASX:CDY)
5.6¢
0 (0%)
MCAP $12.33M
Last trade
14.00pm 09/12/2021
20mins delayed
Latest Announcements
09/12/2021CDYCellmid Limited
535
MCap
09/12/2021CDYCellmid Limited
134
MCap
07/12/2021CDYCellmid Limited
10/11/2021CDYCellmid Limited
1,833
MCap
09/11/2021CDYCellmid Limited
871
MCap
09/11/2021CDYCellmid Limited
09/11/2021CDYCellmid Limited
1,889
MCap
08/11/2021CDYCellmid Limited
305
MCap
Company Overview
Cellmid Limited is an Australia-based health and beauty-tech business company. The Company is specialized in developing anti-aging solutions. The Company operates through two segments: Diagnostics and Consumer Health. The Company is engaged in the research and development of diagnostic and therapeutic products for the management of diseases, such as cancer and various chronic inflammatory conditions by targeting midkine. It is also engaged in the development and sale of over the counter (OTC) and cosmetic products for hair loss and anti-aging hair care through its FGF5 inhibitor technology. It has developed a range of products under the evolis, evolis Professional, Lexilis Hybrid, Jo-JuRED and Lexilis BLACK brands.
